Related Experiment Videos
[Antitumor effect of Corynebacterium parvum on C3H mouse bearing MH-134 tumor]
Abstract:
The antitumor effect of Corynebacterium parvum (C. parvum) was examined by using C3H/He mouse bearing MH-134 ascites hepatoma. The optimal dose of C. parvum was 0.4mg/day intraperitoneally for 5 consecutive days from the 5th day after tumor inoculation. The cell-mediated immunity in this treatment was also investigated by delayed type hypersensitivity (DTH) and macrophage migration inhibition activity (MI). According to the results of both DTH and MI, it was assumed that C. parvum yielded an antitumor effect by restoring the cell-mediated immunity of the tumor bearing host.
Insights
Corynebacterium parvum (C. parvum) demonstrated antitumor effects in mice with ascites hepatoma. This immunotherapy works by enhancing cell-mediated immunity, offering a potential strategy for cancer treatment.
Area of Science:
- Immunology
- Oncology
- Microbiology
Context:
- Hepatocellular carcinoma is a significant global health concern.
- Investigating novel immunotherapeutic agents is crucial for cancer treatment.
- Corynebacterium parvum is a known immunomodulator with potential antitumor properties.
Purpose:
- To evaluate the antitumor efficacy of Corynebacterium parvum (C. parvum) against MH-134 ascites hepatoma in C3H/He mice.
- To determine the optimal dosage and administration schedule for C. parvum.
- To elucidate the immunological mechanisms underlying the observed antitumor effects.
Summary:
- The study identified an optimal dose of 0.4mg/day of C. parvum administered intraperitoneally for five consecutive days in mice bearing MH-134 ascites hepatoma.
- Immunological assessments, including delayed type hypersensitivity (DTH) and macrophage migration inhibition (MI) assays, indicated that C. parvum treatment restored cell-mediated immunity in tumor-bearing hosts.
- These findings suggest that C. parvum exerts its antitumor effect by bolstering the host's immune response.
Impact:
- This research provides evidence for the immunotherapeutic potential of C. parvum in combating hepatocellular carcinoma.
- The study highlights the importance of cell-mediated immunity in tumor regression and suggests C. parvum as a modulator of this response.
- Further investigation into C. parvum-based therapies could lead to novel treatment strategies for liver cancer.